Indian pharma firm Wanbury gains on product launch plans
** Wanbury's shares WANB.NS rise 9%, set for fifth straight session of gains ** Pharma co to launch two new products for formulation, including iron tablets and Ketamine ** Over 255,000 shares traded, 1.6x WANB's 30-day avg ** Stock has surged ~41% in March vs a ~10% rise in Nifty pharma index .NIPHARM (Reporting by Ashna Teresa Britto in Bengaluru) ((AshnaTeresa.Britto@thomsonreuters.com ; ( +91 8078332441))
Recent news on Wanbury
See all newsBrief: Wanbury Says Tanuku API Site Completes TGA Quality Inspection
Brief: Wanbury Expanded Regulatory Submission For New Active Pharmaceutical Ingredients
Brief: Wanbury Says Patalganga Site Has Completed Korea FDA Regulatory Inspection Successfully
Brief: Wanbury Ltd Launches Coriminic CPM Drops For Pediatric Use
Brief: Wanbury Receives Sertraline Form II Approval From Anvisa, Brazil